Developing cancer vaccines is challenging as each tumor is unique has distinguished characteristics. However, accelerated research over the recent years in this field has helped develop a cancer “treatment” vaccine by characterizing these tumor cells. Cancer treatment vaccines are a sort of immunotherapy; they work by boosting the body's immune response. This article talks about groundbreaking research from UK aimed at treatment to prevent head and neck cancer from recurring.
Head and neck cancers are tumors that start in the squamous cells that line the mucosal surfaces of the head and neck. Squamous cell carcinomas of the head and neck are the term for these cancers. A middle-aged man has become the first in the UK to get a 'vaccine' in the hopes of preventing his recurrent head and neck cancer from returning. The patient was diagnosed with cancer in 2011 and had four recurring…
